Advanced search
Publication Cover
Epigenomics Volume 15, 2023 - Issue 2
Submit an article Journal homepage
97
Views
0
CrossRef citations to date
0
Altmetric
Commentary

Transcription Factors: A Potential Therapeutic Target in Head and Neck Squamous Cell Carcinoma

Jayanthi Pazhani1 Department of Biochemistry, Centre of Molecular Medicine&Diagnostics (COMManD), Saveetha Dental College&Hospitals, Saveetha Institute of Medical&Technical Sciences, Saveetha University, Chennai, 600077, India;2 Professor, Azeezia College of Dental Sciences, Kollam, KeralaORCID Iconhttps://orcid.org/0000-0002-9810-7206
ORCID Icon,
Vishnu Priya Veeraraghavan1 Department of Biochemistry, Centre of Molecular Medicine&Diagnostics (COMManD), Saveetha Dental College&Hospitals, Saveetha Institute of Medical&Technical Sciences, Saveetha University, Chennai, 600077, IndiaCorrespondence[email protected]
&
Selvaraj Jayaraman1 Department of Biochemistry, Centre of Molecular Medicine&Diagnostics (COMManD), Saveetha Dental College&Hospitals, Saveetha Institute of Medical&Technical Sciences, Saveetha University, Chennai, 600077, IndiaCorrespondence[email protected]
Pages 57-60 | Received 10 Feb 2023, Accepted 07 Mar 2023, Published online: 28 Mar 2023

References

  • León X , OrúsC , CasasayasM , NeumannE , HolgadoA , QuerM. Trends in disease-specific survival of head and neck squamous cell carcinoma patients treated in a single institution over a 30-year period. Oral Oncol.115, 105184 (2021).
  • He S , ChakrabortyR , RanaganathanS. Proliferation and apoptotic pathways and factors in oral squamous cell carcinoma. Int. J. Mol. Sci.23(3), 1562 (2022).
  • Dong J , LiJ , LiY , MaZ , YuY , WangCY. Transcriptional super-enhancers control cancer stemness and metastasis genes in squamous cell carcinoma. Nat. Commun.12(1), 3974 (2021).
  • Sobolev VV , KhashukoevaAZ , EvinaOEet al. Role of transcription factor FOSL1 in organ development and tumorigenesis. Int. J. Mol. Sci.23, 1521 (2022).
  • Chen D , WuM , LiYet al. Targeting Bmi1+ cancer stem cells overcomes chemoresistance and inhibits metastases in squamous cell carcinoma. Cell Stem Cell20(5), 621–634 (2017).
  • Zhang M , HoyleRG , MaZet al. FOSL1 promotes metastasis of head and neck squamous cell carcinoma through super-enhancer-driven transcription program. Mol. Ther.29(8), 2583–2600 (2021).
  • Kim JS , SonSH , KimMYet al. Diagnostic and prognostic relevance of CP2 and YY1 expression in hepatocellular carcinoma. Oncotarget8(15), 24389–24400 (2017).
  • Schnoell J , JankBJ , Kadletz-WankeLet al. Transcription factors CP2 and YY1 as prognostic markers in head and neck squamous cell carcinoma: analysis of The Cancer Genome Atlas and a second independent cohort. J. Cancer Res. Clin. Oncol.147(3), 755–765 (2021).
  • Cheng P , WangJ , WaghmareIet al. FOXD1-ALDH1A3 signaling is a determinant for the self-renewal and tumorigenicity of mesenchymal glioma stem cells. Cancer Res.76(24), 7219–7230 (2016).
  • Zhao YF , ZhaoJY , YueHet al. FOXD1 promotes breast cancer proliferation and chemotherapeutic drug resistance by targeting p27. Biochem. Biophys. Res. Commun.456(1), 232–237 (2015).
  • Li J , YanT , WuXet al. Aberrant overexpression of transcription factor Forkhead box D1 predicts poor prognosis and promotes cancer progression in HNSCC. BMC Cancer21(1), 1205 (2021).
  • Awasthee N , RaiV , ChavaSet al. Targeting IKappa B kinases for cancer therapy. Semin. Cancer Biol.56, 12–24 (2019).
  • Yu H , LinL , ZhangZ , ZhangH , HuH. Targeting NF-κB pathway for the therapy of diseases: mechanism and clinical study. Signal Transduct. Target Ther.5(1), 209 (2020).
  • Kumar V , KumarA , KumarM , LoneMR , MishraD , ChauhanSS. NFκB (RelA) mediates transactivation of hnRNPD in oral cancer cells. Sci. Rep.12(1), 5944 (2022).
  • Song A , WangY , JiangFet al. Ubiquitin D promotes progression of oral squamous cell carcinoma via NF-Kappa B signaling. Mol. Cells44(7), 468–480 (2021).
  • El-din YA , SabryD , AhmedSHet al. FOXD1-mTOR signaling pathway on oral squamous cell carcinoma and its inhibition by rosemary extract (invitro-study). Asian Pac. J. Cancer Prev.23(9), 3071–3081 (2022).
  • Yang J , AmiriKI , BurkeJRet al. BMS-345541 targets inhibitor of κB kinase and induces apoptosis in melanoma: involvement of nuclear factor κB and mitochondria pathways. Clin. Cancer Res.12(3), 950–960 (2006).
  • Richardson PG , BarlogieB , BerensonJet al. A phase 2 study of bortezomib in relapsed refractory myeloma. N. Engl. J. Med.348(26), 2609–2617 (2003).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.